title: Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
authors.affiliation: Arkadi M. Rywlin Department of Pathology, Mount Sinai Medical Center, Miami Beach, Florida, USA. dpeker@msmc.com
authors.forename: Deniz
authors.initials: D
authors.lastname: Peker
authors.forename: Antonio E
authors.initials: AE
authors.lastname: Martinez
authors.forename: Michael A
authors.initials: MA
authors.lastname: Schwartz
authors.forename: Mike
authors.initials: M
authors.lastname: Cusnir
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005871:Castleman Disease / Q000150:complications / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage; D015658:HIV Infections / Q000821:virology; D006566:Herpesviridae Infections / Q000150:complications; D019288:Herpesvirus 8, Human; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D004317:Doxorubicin